LIF is an autocrine factor for sympathetic neurons

Molecular and Cellular Neurosciences

Volumn 9, Issue 5-6, 1997, Pages 372-380

  Cheng, Jr Gang ^a   Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

CNTF; Gp130; Leukemia inhibitory factor

Indexed keywords

CYTOKINE; LEUKEMIA INHIBITORY FACTOR; NEUROPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE CELL; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL;

ANIMALIA;

EID: 0030705179     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1997.0635     Document Type: Article

References (34)

1. Adler J. E., Black I. B. Sympathetic neuron density differentially regulates transmitter phenotypic expression in culture. Proc. Natl. Acad. Sci. USA. 82:1985;4296-4300.
2. Bamber B. A., Masters B. A., Hoyle G. W., Brinster R. L., Palmiter R. D. Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;7839-7843.
3. Banner L. R., Patterson P. H. Major changes in the expression of the mRNAs for CDF/LIF and its receptor after injury to adult peripheral nerves and ganglia. Proc. Natl. Acad. Sci. USA. 91:1994;7109-7113.
4. Banner L. R., Moayeri N. N., Patterson P. H. Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury. Exp. Neurol. 147:1997;1-9.
5. Corness J., Shi T. J., Xu Z. Q., Brulet P., Hokfelt T. Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide-Y expression in mouse primary sensory neurons after axotomy. Exp. Brain Res. 112:1996;79-88.
6. Curtis R., Scherer S., Somogyi R., Adryan K. M., Ip N. Y., Zhu Y., Lindsay R. M., DiStefano P. S. Retrograde axonal transport of LIF is increased by peripheral nerve injury: Correlation with increased LIF expression in distal nerve. Neuron. 12:1994;191-204.
7. Davies A. M. Paracrine and autocrine actions of neurotrophin factors. Neurochem. Res. 21:1996;749-753.
8. Fann M.-J., Patterson P. H. A novel approach to screen for cytokine effects on neuronal gene expression. J. Neurochem. 61:1993;1349-1355.
9. Fann M.-J., Patterson P. H. Neuropoietic cytokines and activin-A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl. Acad. Sci. USA. 91:1994a;43-47.
10. Fann M. J., Patterson P. H. Depolarization differentially regulates the effects of bone morphogenetic protein (BMP)-2, BMP-6 and activin A on sympathetic neuronal phenotype. J. Neurochem. 63:1994b;2074-2079.
11. Gadient R. A., Otten U. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNA in rat sympathetic and sensory ganglia. Brain Res. 724:1996;41-46.
12. Gallagher S. R., Smith J. A. Analysis of Proteins. Current Protocols in Molecular Biology. 1987;Greene Publishing Associates and Wiley-Interscience, Wiley, New York. p. 10.2.17-.
13. Lemke R., Gadient R. A., Schliebs R., Bigl V., Patterson P. H. Neuronal expression of leukemia inhibitory factor (LIF) in the rat brain. Neurosci. Lett. 215:1996;205-208.
14. Lemke R., Gadient R. A., Patterson P. H., Bigl V., Schliebs R. Leukemia inhibitory factor (LIF) mRNA-expressing neuronal subpopulations in adult rat forebrain. Neurosci. Lett. 229:1997;69-71.
15. Lindholm D., Carroll P., Tzimagiorgis G., Thoenen H. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur. J. Neurosci. 8:1996;1452-1460.
16. Mayer M., Bhakoo K., Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 120:1994;143-153.
17. Metcalf D. The leukemia inhibitory factor (LIF). Int. J. Cell Cloning. 9:1991;95-108.
18. Minami M., Kuraishi Y., Satoh M. Effect of kainic acid on messenger RNA levels of IL-1b, IL-6, TNFa and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
19. Nakagaito Y., Yoshida T., Satoh M., Takeuchi M. Effects of leukemia inhibitory factor on the differentiation of astrocyte progenitor cells from embryonic mouse cerebral hemispheres. Dev. Brain Res. 87:1995;220-223.
20. Nawa H., Nakanishi S., Patterson P. H. Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J. Neurochem. 56:1991;2147-2150.
21. Patterson P. H., Fann M. J. Further studies of the distribution of CDF/LIF mRNA. Ciba Foundation Symp. 167:1992;125-140.
22. Qiu L., Towle M. F., Bernd P., Fukada K. Distribution of cholinergic neuronal differentiation factor/leukemia inhibitory factor binding sites in the developing and adult rat nervous system in vivo. J. Neurobiol. 32:1997;163-192.
23. Rao M. S., Escary J. L., Sun Y., Perreau J., Patterson P. H., Zigmond R. E., Brulet P., Landis S. C. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron. 11:1993;1175-1185.
24. Rao M. S., Landis S. C., Patterson P. H. Membrane-associated neurotransmitter stimulating factor is very similar to ciliary neurotrophic factor. Dev. Biol. 153:1992a;411-416.
25. Rao M. S., Tyrrell S., Landis S. C., Patterson P. H. Effects of ciliary neurotrophic factor (CNTF) and depolarization on neuropeptide expression in cultured sympathetic neurons. Dev. Biol. 150:1992b;281-293.
26. Rathjen P. D., Toth S., Willis A., Heath J. K., Smith A. G. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell. 62:1990;1105-1114.
27. Schobitz B., Kloet E. R. d., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
28. Sun Y., Rao M., Zigmond R. E., Landis S. C. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor. J. Neurobiol. 25:1994;415-430.
29. Sun S., Landis S. C., Zigmond R. E. Signals triggering the induction of leukemia inhibitory factor in sympathetic superior cervical ganglia and their nerve trunks after axonal injury. Mol. Cell. Neurosci. 7:1996;152-163.
30. Sun Y., Zigmond R. E. Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal-peptide messenger-RNA and the decreases in neuropeptide Y and tyrosine hydroxylase messenger RNA in sympathetic neurons after axotomy. J. Neurochem. 67:1996;1751-1760.
31. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
32. Waring P., Wycherley K., Cary D., Nicola N., Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and in various inflammatory body fluids. J. Clin. Invest. 90:1992;2031-2037.
33. Wong V., Kessler J. Solubilization of a membrane factor that stimulates levels of substance P and choline acetyltransferase in sympathetic neurons. Proc. Natl. Acad. Sci. USA. 84:1987;8726-8729.
34. Yamakuni H., Minami M., Satoh M. Localization of messenger-RNA for leukemia inhibitory factor receptor in the adult rat brain. J. Neuroimmunol. 70:1996;45-53.